As one of the most cutting-edge industry sectors around the world, the Healthcare, Life Sciences and Pharmaceutical fields demand a partner with an in-depth understanding of the huge commercial pressures, growing regulatory scrutiny and vital significance of medical breakthroughs and advances. Tadmor Levy & Co. is your partner.
Ranked in Tier 1 by Legal 500, we draw praise for being “a truly excellent firm with specific expertise in the healthcare industry”, working daily with hospitals, such as Assuta Medical Centers, Israel’s largest chain of private hospitals, as well as healthcare providers, pharmaceutical, bio-med, medical device and cannabis companies, state-sponsored incubators, start-ups and growth companies operating in the healthcare sector, and many more.
Headed by Efrat Shapira Orren, ranked a “Leading Individual” by Legal 500, our Life Sciences, Healthcare and Pharmaceutical team represents these clients in a wide and complex variety of issues, transactional, contentious and regulatory.
This representation includes regulatory compliance; governance; licensing; clinical trials and research agreements; strategic research collaboration agreements; data use agreements with medical start-up companies and investment funds; development of hospitals and other healthcare facilities, including PPP projects; international medical consultation agreements; hospital-physician relationships; commercial agreements relating to the supply of medical services; hospital-insurers agreements; privacy, security and database registry; M&A, corporate structuring; donations and fundraising for medical institutions; antitrust law; employment and labor law; litigation and dispute resolution and more.
Domestically, we have been involved in the operation of the first public hospital to be constructed in Israel in the last 40 years, while we have also been involved in a range of cross-border activity, such as advising on tenders issued for building new hospitals in Europe and on transactions relating to the design, construction and operation of hospitals globally. We recently represented several health organizations in negotiations concerning the establishment of an investment fund in the area of Healthcare and Digital Health. Showcasing our breadth and depth of litigation capabilities, we recently worked with our Litigation department to advise pharmaceutical multinational, Allergan Plc, with respect to a motion to certify a derivative action valued at USD 300 million.
Our breadth of experience in representing clients right across the spectrum reassures clients who depend on our commercially-focused and targeted advice, and inside knowledge of the opportunities and challenges of these sectors.